GLYCEROPHOSPHOLIPIDS FOR THE IMPROVEMENT OF COGNITIVE FUNCTIONS
The present document relates to a method of improving a condition in a subject suffering from a cognitive disease or disorder which comprises administering to the subject an effective amount of a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates, where t...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | RICHTER, YAEL FARKASH, ORLY SHULMAN, AVIDOR BEN DROR, GAI PELLED, DORI PLATT, DORIT ZUABI, RASSAN BAR-ON, ZOHAR |
description | The present document relates to a method of improving a condition in a subject suffering from a cognitive disease or disorder which comprises administering to the subject an effective amount of a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates, where the mixture comprises (a) linoleic acid (c18:2) conjugated to phosphatidylserine (PS), (b) docosahexaenoic acid (DHA) conjugated to PS, and (f) eicosapentaenoic acid (EPA) conjugated to PS, in which mixture the w/w% of (a) / the w/w% of (b) is from about 0.09 to about 3.6 and the w/w% of (a) / w/w% of (f) is from about 0.23 to about 9.4.
La présente invention a trait à une méthode visant à améliorer létat dun sujet souffrant dune maladie ou dun trouble cognitif qui comprend ladministration au sujet dune quantité efficace dune préparation comprenant un mélange fait de conjugués de glycérophospholipides sériniques tirés dorganismes non mammaliens, le mélange comprenant (a) de lacide linoléique (c18:2) conjugué à de la phosphatidylsérine (PS), (b) de lacide docosahexaénoïque (DHA) conjugué à de la PS et (f) de lacide eicosapentaénoïque (EPA) conjugué à de la PS, dans lequel le pourcentage en poids de (a)/ pourcentage en poids de (b) est denviron 0,09 à environ 3,6 et le pourcentage en poids de (a)/pourcentage en poids de (f) est denviron 0,23 à environ 9,4. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2847644C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2847644C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2847644C3</originalsourceid><addsrcrecordid>eNrjZLB394l0dg3yD_DwDwZiH88AT5dgBTf_IIUQD1cFT9-AIP8wV19XvxAFfzcFZ393P88QzzBXBbdQP-cQT3-_YB4G1rTEnOJUXijNzSDv5hri7KGbWpAfn1pckJicmpdaEu_saGRhYm5mYuJsTFgFACW1KiE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GLYCEROPHOSPHOLIPIDS FOR THE IMPROVEMENT OF COGNITIVE FUNCTIONS</title><source>esp@cenet</source><creator>RICHTER, YAEL ; FARKASH, ORLY ; SHULMAN, AVIDOR ; BEN DROR, GAI ; PELLED, DORI ; PLATT, DORIT ; ZUABI, RASSAN ; BAR-ON, ZOHAR</creator><creatorcontrib>RICHTER, YAEL ; FARKASH, ORLY ; SHULMAN, AVIDOR ; BEN DROR, GAI ; PELLED, DORI ; PLATT, DORIT ; ZUABI, RASSAN ; BAR-ON, ZOHAR</creatorcontrib><description>The present document relates to a method of improving a condition in a subject suffering from a cognitive disease or disorder which comprises administering to the subject an effective amount of a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates, where the mixture comprises (a) linoleic acid (c18:2) conjugated to phosphatidylserine (PS), (b) docosahexaenoic acid (DHA) conjugated to PS, and (f) eicosapentaenoic acid (EPA) conjugated to PS, in which mixture the w/w% of (a) / the w/w% of (b) is from about 0.09 to about 3.6 and the w/w% of (a) / w/w% of (f) is from about 0.23 to about 9.4.
La présente invention a trait à une méthode visant à améliorer létat dun sujet souffrant dune maladie ou dun trouble cognitif qui comprend ladministration au sujet dune quantité efficace dune préparation comprenant un mélange fait de conjugués de glycérophospholipides sériniques tirés dorganismes non mammaliens, le mélange comprenant (a) de lacide linoléique (c18:2) conjugué à de la phosphatidylsérine (PS), (b) de lacide docosahexaénoïque (DHA) conjugué à de la PS et (f) de lacide eicosapentaénoïque (EPA) conjugué à de la PS, dans lequel le pourcentage en poids de (a)/ pourcentage en poids de (b) est denviron 0,09 à environ 3,6 et le pourcentage en poids de (a)/pourcentage en poids de (f) est denviron 0,23 à environ 9,4.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160809&DB=EPODOC&CC=CA&NR=2847644C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160809&DB=EPODOC&CC=CA&NR=2847644C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RICHTER, YAEL</creatorcontrib><creatorcontrib>FARKASH, ORLY</creatorcontrib><creatorcontrib>SHULMAN, AVIDOR</creatorcontrib><creatorcontrib>BEN DROR, GAI</creatorcontrib><creatorcontrib>PELLED, DORI</creatorcontrib><creatorcontrib>PLATT, DORIT</creatorcontrib><creatorcontrib>ZUABI, RASSAN</creatorcontrib><creatorcontrib>BAR-ON, ZOHAR</creatorcontrib><title>GLYCEROPHOSPHOLIPIDS FOR THE IMPROVEMENT OF COGNITIVE FUNCTIONS</title><description>The present document relates to a method of improving a condition in a subject suffering from a cognitive disease or disorder which comprises administering to the subject an effective amount of a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates, where the mixture comprises (a) linoleic acid (c18:2) conjugated to phosphatidylserine (PS), (b) docosahexaenoic acid (DHA) conjugated to PS, and (f) eicosapentaenoic acid (EPA) conjugated to PS, in which mixture the w/w% of (a) / the w/w% of (b) is from about 0.09 to about 3.6 and the w/w% of (a) / w/w% of (f) is from about 0.23 to about 9.4.
La présente invention a trait à une méthode visant à améliorer létat dun sujet souffrant dune maladie ou dun trouble cognitif qui comprend ladministration au sujet dune quantité efficace dune préparation comprenant un mélange fait de conjugués de glycérophospholipides sériniques tirés dorganismes non mammaliens, le mélange comprenant (a) de lacide linoléique (c18:2) conjugué à de la phosphatidylsérine (PS), (b) de lacide docosahexaénoïque (DHA) conjugué à de la PS et (f) de lacide eicosapentaénoïque (EPA) conjugué à de la PS, dans lequel le pourcentage en poids de (a)/ pourcentage en poids de (b) est denviron 0,09 à environ 3,6 et le pourcentage en poids de (a)/pourcentage en poids de (f) est denviron 0,23 à environ 9,4.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB394l0dg3yD_DwDwZiH88AT5dgBTf_IIUQD1cFT9-AIP8wV19XvxAFfzcFZ393P88QzzBXBbdQP-cQT3-_YB4G1rTEnOJUXijNzSDv5hri7KGbWpAfn1pckJicmpdaEu_saGRhYm5mYuJsTFgFACW1KiE</recordid><startdate>20160809</startdate><enddate>20160809</enddate><creator>RICHTER, YAEL</creator><creator>FARKASH, ORLY</creator><creator>SHULMAN, AVIDOR</creator><creator>BEN DROR, GAI</creator><creator>PELLED, DORI</creator><creator>PLATT, DORIT</creator><creator>ZUABI, RASSAN</creator><creator>BAR-ON, ZOHAR</creator><scope>EVB</scope></search><sort><creationdate>20160809</creationdate><title>GLYCEROPHOSPHOLIPIDS FOR THE IMPROVEMENT OF COGNITIVE FUNCTIONS</title><author>RICHTER, YAEL ; FARKASH, ORLY ; SHULMAN, AVIDOR ; BEN DROR, GAI ; PELLED, DORI ; PLATT, DORIT ; ZUABI, RASSAN ; BAR-ON, ZOHAR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2847644C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2016</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>RICHTER, YAEL</creatorcontrib><creatorcontrib>FARKASH, ORLY</creatorcontrib><creatorcontrib>SHULMAN, AVIDOR</creatorcontrib><creatorcontrib>BEN DROR, GAI</creatorcontrib><creatorcontrib>PELLED, DORI</creatorcontrib><creatorcontrib>PLATT, DORIT</creatorcontrib><creatorcontrib>ZUABI, RASSAN</creatorcontrib><creatorcontrib>BAR-ON, ZOHAR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RICHTER, YAEL</au><au>FARKASH, ORLY</au><au>SHULMAN, AVIDOR</au><au>BEN DROR, GAI</au><au>PELLED, DORI</au><au>PLATT, DORIT</au><au>ZUABI, RASSAN</au><au>BAR-ON, ZOHAR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GLYCEROPHOSPHOLIPIDS FOR THE IMPROVEMENT OF COGNITIVE FUNCTIONS</title><date>2016-08-09</date><risdate>2016</risdate><abstract>The present document relates to a method of improving a condition in a subject suffering from a cognitive disease or disorder which comprises administering to the subject an effective amount of a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates, where the mixture comprises (a) linoleic acid (c18:2) conjugated to phosphatidylserine (PS), (b) docosahexaenoic acid (DHA) conjugated to PS, and (f) eicosapentaenoic acid (EPA) conjugated to PS, in which mixture the w/w% of (a) / the w/w% of (b) is from about 0.09 to about 3.6 and the w/w% of (a) / w/w% of (f) is from about 0.23 to about 9.4.
La présente invention a trait à une méthode visant à améliorer létat dun sujet souffrant dune maladie ou dun trouble cognitif qui comprend ladministration au sujet dune quantité efficace dune préparation comprenant un mélange fait de conjugués de glycérophospholipides sériniques tirés dorganismes non mammaliens, le mélange comprenant (a) de lacide linoléique (c18:2) conjugué à de la phosphatidylsérine (PS), (b) de lacide docosahexaénoïque (DHA) conjugué à de la PS et (f) de lacide eicosapentaénoïque (EPA) conjugué à de la PS, dans lequel le pourcentage en poids de (a)/ pourcentage en poids de (b) est denviron 0,09 à environ 3,6 et le pourcentage en poids de (a)/pourcentage en poids de (f) est denviron 0,23 à environ 9,4.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_CA2847644C |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | GLYCEROPHOSPHOLIPIDS FOR THE IMPROVEMENT OF COGNITIVE FUNCTIONS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A33%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RICHTER,%20YAEL&rft.date=2016-08-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2847644C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |